Publications found:
410
Sort by:
Global Tizanidine HCl Market Growth 2025-2031
US$ 3,660.00
The global Tizanidine HCl market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff...
October 2025
111 pages
Opioid Withdrawal Syndrome Market - 2024-2031
US$ 3,400.00
Opioid Withdrawal Syndrome Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Opioid Withdrawal Syndrome Market emerges as a key focus in DataM Intelligence latest in-d...
October 2025
52 pages
Global Friedreich's Ataxia (FA) Market - 2025 -2033
US$ 4,350.00
Friedreich’s Ataxia (FA) Market Size In 2023, the global Friedreich’s Ataxia (FA) market was valued at US$ 0.86 Billion. The global Friedreich’s ataxia (FA) market size reached US$ 0.96 Billion in 202...
October 2025
180 pages
Global Rett Syndrome Market - 2025 -2033
US$ 4,350.00
Rett Syndrome Market Size The global Rett syndrome market size reached US$ 409.88 Million in 2024 from US$ 374.98 Million in 2023 and is expected to reach US$ 972.11 Million by 2033, growing at a CAGR...
October 2025
180 pages
Global Sleep Aids Market - 2025 -2033
US$ 4,350.00
Sleep Aids Market Size and Trends The global sleep aids market reached US$ 60.96billion in 2023, with a rise to US$ 65.20 billion in 2024, and is expected to reach US$ 118.97billion by 2033, growing a...
October 2025
180 pages
Global Benzodiazepine Drugs Market Growth 2025-2031
US$ 3,660.00
The global Benzodiazepine Drugs market size is predicted to grow from US$ 1522 million in 2025 to US$ 2074 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031. Benzodiazepine d...
September 2025
139 pages
India Gabapentin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Gabapentin Market was valued at USD 74.52 Million in 2025 and is expected to reach USD 108.57 Million by 2031, growing with a CAGR of 6.31% in the forecast period. The gabapentin market in India...
September 2025
70 pages
Medical Marijuana Market - 2025-2033
US$ 3,400.00
Medical Marijuana Marketis is growing with a CAGR of 20.90% during the forecast period 2026-2035. The Medical Marijuana Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...
September 2025
43 pages
Global Guanfacine Market Growth 2025-2031
US$ 3,660.00
The global Guanfacine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Guanfacine is e...
September 2025
111 pages
Global Butylphthalide Soft Capsule Market Growth 2025-2031
US$ 3,660.00
The global Butylphthalide Soft Capsule market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Butylphthalide Soft Cap...
September 2025
99 pages
Precision Psychiatry Market Size, Share & Trends Analysis Report By Service Type (Genetic Testing, Biomarker Analysis), By Technology (Immunoassay, Polymerase Chain Reaction), By Therapeutic Area (Hospitals & Clinics, Clinical Laboratories), By End-user, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Precision Psychiatry Market The global precision psychiatry market size was estimated at USD 825.6 million in 2024 and is projected to reach USD 2,858.0 million by 2033, growing at a CAGR of 14.91% fr...
September 2025
120 pages
Tuberous Sclerosis Treatment Market - 2024-2031
US$ 3,400.00
Tuberous Sclerosis Treatment Marketis is growing with a CAGR of 7.30% during the forecast period 2026-2035. The Tuberous Sclerosis Treatment Market emerges as a key focus in DataM Intelligence latest...
September 2025
54 pages
ADHD Focus Wearables Market Forecasts to 2032 – Global Analysis By Product (Smartwatches, Headbands & Neurofeedback Devices, Smart Glasses, Wearable Sensors and Other Products), Distribution Channel, Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global ADHD Focus Wearables Market is accounted for $737.9 million in 2025 and is expected to reach $2,110.7 million by 2032 growing at a CAGR of 16.2% during the for...
September 2025
200 pages
Alzheimer's Drugs Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class [Cholinesterase Inhibitors (Donepezil, Rivastigmine, and Galantamine) NMDA Receptor Antagonists, Combination Drugs, and Others] and End User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 4,450.00
The Alzheimer's drugs market size is expected to grow from US$ 8.24 billion in 2024 to US$ 26.37 billion by 2031; it is projected to register a CAGR of 13.6% during 2025-2031. The aging population & r...
August 2025
215 pages
Multiple Sclerosis Therapies Market Report by Drug (Immunomodulators, Immunosuppressants), Drug Type (Biologic Drugs, Small Molecule Drugs), Route of Administration (Oral, Injectable, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
US$ 2,999.00
The global multiple sclerosis therapies market size reached USD 27.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 38.8 Billion by 2033, exhibiting a growth rate (CAGR)...
August 2025
120 pages
Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033
US$ 2,999.00
The global neurodegenerative disease treatment market size reached USD 78.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 118.5 Billion by 2033, exhibiting a growth rat...
August 2025
124 pages
Anti-Parkinson’s Drugs: Global Markets to 2030
US$ 4,650.00
... global market for anti-Parkinson’s drugs and their future demand Analyses of global market trends, with ... printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs ...
July 2025
134 pages
Global Friedreich's Ataxia Market - 2025-2033
US$ 3,400.00
Global Friedreich's Ataxia Market reached US$ 0.96 Billion in 2024 and is expected to reach US$ 2.86 Billion by 2033, growing with a CAGR of 7.70% during the forecast period 2026-2033. The Global Frie...
July 2025
52 pages
Epilepsy Drugs Market - 2025-2033
US$ 3,400.00
Epilepsy Drugs Market reached US$ 11.09 Billion in 2024 and is expected to reach US$ 16.73 Billion by 2033, growing with a CAGR of 4.20% during the forecast period 2026-2033. The Epilepsy Drugs Market...
June 2025
40 pages
Global Rett Syndrome Market - 2025-2033
US$ 3,400.00
Global Rett Syndrome Market reached US$ 409.88 Million in 2024 and is expected to reach US$ 972.11 Million by 2033, growing with a CAGR of 10.10% during the forecast period 2026-2033. The Global Rett...
June 2025
46 pages
Global Spinocerebellar Ataxia Market - 2025-2033
US$ 3,400.00
Global Spinocerebellar Ataxia Marketis is growing with a CAGR of 7.40% during the forecast period 2026-2035. The Global Spinocerebellar Ataxia Market emerges as a key focus in DataM Intelligence lates...
June 2025
55 pages